Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 13,263,517
- Share change
- -111,312
- Total reported value
- $53,451,000
- Price per share
- $4.03
- Number of holders
- 13
- Value change
- -$728,128
- Number of buys
- 4
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
4.6%
|
5,940,796
|
$39,090,000 | — | 30 Jun 2020 | |
| TPG Group Holdings (SBS) Advisors, Inc. |
13F
|
Company |
3.8%
|
4,824,883
|
$31,748,000 | — | 30 Jun 2020 | |
| Omega Fund Management, LLC |
13F
|
Company |
1.1%
|
1,375,907
|
$9,053,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
0.62%
|
792,700
|
$5,216,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.11%
|
138,915
|
$914,000 | — | 30 Jun 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
100,000
|
$658,000 | — | 30 Jun 2020 | |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. |
13F
|
Company |
0.05%
|
70,000
|
$460,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
41,913
|
$275,000 | — | 30 Jun 2020 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
40,000
|
$263,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
23,713
|
$155,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,002
|
$105,000 | — | 30 Jun 2020 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
10,000
|
$66,000 | — | 30 Jun 2020 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q3 2020
As of 30 Sep 2020,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,263,517 shares.
The largest 10 holders included
NEA Management Company, LLC, TPG Group Holdings (SBS) Advisors, Inc., Omega Fund Management, LLC, FMR LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, and LPL Financial LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
12
Q3 2020 holders
13
Holder diff
1
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.